Trials / Completed
CompletedNCT03554525
Weight Regain After Consumption of Food Supplement and Interventional Diet Program
Clinical Trial to Evaluate the Usefulness of the Regular Consumption of a Food Supplement(FAT-BINDER DAMM) on Weight Regain After an Interventional Diet Program on Overweight/Obese People
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Effect of the dietary supplement (FAT-BINDER DAMM) on weight regain after 9 months of control weight program
Detailed description
* 60 participants will consume experimental product every day 3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the 12 first weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period). When PPP period is over, volunteers will continue consuming the product for 9 months more (Post-PPP period). * 60 participants will consume everyday 3 placebo sticks (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the first 12 weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period ). When PPP period is over, volunteers will continue consuming the product for 9 months more.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Fat-binder damm | 3 sticks every day during 12 months |
| DIETARY_SUPPLEMENT | Placebo | 3 sticks every day during 12 months |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2018-06-13
- Last updated
- 2019-04-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03554525. Inclusion in this directory is not an endorsement.